Class 10 and 12 Board Exam 2022: CISCE releases notice, set of instructions for candidates

-

The Council for the Indian School Certificate Examinations (CISCE) has released a set of important instructions for students who are not awarded pass certificates, supplementary candidates, and absent or withdrawn candidates. This notice is for applicants appearing for the Indian Certificate of Secondary Education (ICSE) and Indian School Certificate (ISC) Board Exam 2022.

Candidates can access the notice and read the important instructions by visiting the official website of CISCE - https://cisce.org/.

“It may be noted that this is a special provision that has been put in place for the year 2022 exams as an exception and should not be considered as a precedent for the future,” the official notice released by the CISCE reads.

Candidates who have not availed the pass certificate and wish to re-appear for the examination next year can do so by applying from their respective schools as regular students for a complete certificate.

Those who wish to appear for only one or more subjects just to improve their grades can apply and appear for supplementary exams. Also, such students are requested to follow the bifurcated syllabus set by the board. Moreover, if any student is absent and wants to appear for an examination can do so by appearing in regular attendance at the school for a full certificate.

However, all these candidates will have to appear for semester I and semester II of the examinations, as per the official notice.

Concerning the question paper pattern, the board has also informed that the exam pattern will be identical to the question paper which was followed for ICSE, ISC examinations conducted this year.

Along with the above concerning exams, the council will be conducting compartment examinations for students who have not been awarded a pass certificate but have passed in English and three other main subjects in Class 10. While, for Class 12, the board will conduct exams in English and two other subjects.



from Firstpost India Latest News https://ift.tt/3h1QeMi
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more